Skip to main content
Clinical Trials/NCT07825636
NCT07825636CompletedNot Applicable

Sensorimotor Function Impairment in Chronic Obstructive Pulmonary Disease

Alanya Alaaddin Keykubat University1 site in 1 country95 target enrollmentStarted: October 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
95
Locations
1
Primary Endpoint
Montreal Cognitive Assessment

Study Overview

Brief Summary

The aim of this study was to investigate the level of sensorimotor function impairment according to disease stage in individuals with Chronic Obstructive Pulmonary Disease (COPD) and to determine whether functional differences exist between individuals with COPD and healthy controls.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
40 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Individuals diagnosed with COPD,
  • Aged 40-65 years, who volunteer to participate in the study,
  • Who do not have additional musculoskeletal disorders, neurological or cardiorespiratory problems, or respiratory failure (not using long-term home oxygen therapy or non-invasive mechanical ventilation) will be included.
  • Inclusion Criteria for Healthy Individuals:
  • Individuals aged 40-65 years who volunteer to participate in the study,
  • Who do not have additional musculoskeletal disorders, neurological or cardiorespiratory problems,
  • Who do not have communication problems will be included.

Exclusion Criteria

  • Exclusion Criteria for Individuals with COPD
  • Individuals with uncorrected visual and hearing impairment,
  • Individuals with a diagnosed serious chronic disease (neurological disease, cancer, chronic heart failure, etc.).
  • Exclusion Criteria for Healthy Individuals
  • Individuals with uncorrected visual and hearing impairment,
  • A diagnosed serious chronic disease (neurological disease, cancer, chronic heart failure, etc.) will be excluded from the study.

Arms & Interventions

Healthy Control

COPD Group

Outcomes

Primary Outcomes

Montreal Cognitive Assessment

Time Frame: Enrollment

Cognitive function was assessed using the Montreal Cognitive Assessment. The scale evaluates various cognitive domains, such as executive functions, visuospatial skills, attention, memory, language, abstraction, and orientation. The total score was calculated out of 30 points.

Pain Pressure Threshold and Tolerance

Time Frame: Enrollment

Pain threshold and pain tolerance were assessed using a digital pressure algometer (J-Tech Commander algometer, Preston Co., USA). Two measurements were taken from each site, and the mean value was used in the analysis.

Muscle Quality Index

Time Frame: Enrollment

Muscle quality was assessed using the Muscle Quality Index, calculated based on the duration of the 5-repetition sit-to-stand test, body weight, and leg length.

Secondary Outcomes

  • Lower Extremity Coordination Test(Enrollment)

Investigators

Sponsor
Alanya Alaaddin Keykubat University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ayse Unal

Assoc. Prof, PT.PhD.

Alanya Alaaddin Keykubat University

Study Sites (1)

Loading locations...

Similar Trials